BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 85 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $336,171 | -65.0% | 132,874 | -7.8% | 0.00% | – |
| Q2 2023 | $959,346 | -68.6% | 144,046 | -12.0% | 0.00% | -100.0% |
| Q1 2023 | $3,053,710 | +166.1% | 163,650 | +206.3% | 0.00% | – |
| Q4 2022 | $1,147,547 | +3.8% | 53,424 | -42.9% | 0.00% | – |
| Q3 2022 | $1,106,000 | +15.3% | 93,509 | +28.7% | 0.00% | – |
| Q2 2022 | $959,000 | -33.3% | 72,674 | +5.7% | 0.00% | – |
| Q1 2022 | $1,437,000 | +42.1% | 68,748 | +38.2% | 0.00% | – |
| Q4 2021 | $1,011,000 | -7.3% | 49,734 | +38.3% | 0.00% | – |
| Q3 2021 | $1,091,000 | -78.9% | 35,969 | -79.7% | 0.00% | -100.0% |
| Q2 2021 | $5,160,000 | -5.5% | 177,590 | +40.4% | 0.00% | 0.0% |
| Q1 2021 | $5,458,000 | -53.0% | 126,465 | -49.7% | 0.00% | -66.7% |
| Q4 2020 | $11,617,000 | +77.9% | 251,443 | +66.9% | 0.00% | +50.0% |
| Q3 2020 | $6,530,000 | +23.2% | 150,611 | +50.6% | 0.00% | 0.0% |
| Q2 2020 | $5,300,000 | +374.9% | 99,979 | +100.3% | 0.00% | – |
| Q1 2020 | $1,116,000 | +1038.8% | 49,911 | +370.0% | 0.00% | – |
| Q2 2018 | $98,000 | -65.6% | 10,620 | -61.9% | 0.00% | – |
| Q1 2018 | $285,000 | – | 27,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 40,000 | $836,000 | 1.01% |
| ACT CAPITAL MANAGEMENT, LLC | 20,000 | $418,000 | 0.44% |
| Knoll Capital Management, LLC | 20,000 | $418,000 | 0.26% |
| Artemis Investment Management LLP | 1,428,228 | $29,855,000 | 0.24% |
| Rubric Capital Management LP | 268,528 | $5,615,000 | 0.20% |
| Virtus ETF Advisers LLC | 7,713 | $161,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 107,700 | $2,252,000 | 0.05% |
| PDT Partners, LLC | 28,031 | $586,000 | 0.05% |
| AllSquare Wealth Management LLC | 3,162 | $66,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 35,221 | $736,000 | 0.04% |